Drug details:
Molecular formula: C₁₅H₁₃BrN₂O₂

Standard name: N-[(E)-(5-bromo-2-hydroxyphenyl)methylideneamino]-2-phenylacetamide

Synonyms:

N'-(5-bromo-2-hydroxybenzylidene)-2-phenylacetohydrazide N'-[(1E)-(5-bromo-2-hydroxyphenyl)methylene]-2-phenylacetohydrazide

Curated SMILES: O=C(CC1=CC=CC=C1)N/N=C/C1=CC(Br)=CC=C1O

Evidence for compound's anti-virulence activity:

Chlamydia
Related VF: TTSS (Type III secretion system)
Target: Not determined
Drug effect: Inhibits T3SS activity.
Max phase: Preclinical (in vitro)
Publication:
Dahlgren MK, et al., 2010. Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Bioorg Med Chem 18(7):2686-703.